![]() Back to Conference page
|
UICC World Cancer Congress 2006Bridging the Gap: Transforming Knowledge into ActionJuly 8-12, 2006, Washington, DC, USA |
Methods:We examined the expression of ERRs in endometrial carcinoma tissues and normal endometrium tissues using semi-quantitative RT-PCR and immunohistochemistry. Clinicopathologic features including FIGO stage, histological grade, myometrial invasion and nodal metastasis were also reviewed. The statistical analysis was performed via SPSS 10.0 software.
Results:It showed that the mRNA levels of ERRá, â and ã were positively associated with the immunoreactivity respectively (P=0.009, P=0.014 and P=0.001). The expression rate and relative level of ERRá mRNA in ERá-positive endometrial carcinoma tissues were lower than ERá-positive normal endometrium tissues (P=0.049 and P=0.023, respectively). Compared with normal endometrium tissues, a higher expression level of ERRã mRNA was observed in ERá-positive endometrial carcinomas (P=0.014). Spearman's correlation analysis showed that the expression of ERRá mRNA significantly correlated with the FIGO stage (P=0.019) and myometrial invasion (P=0.043). Higher expression of ERRá mRNA was positively associated with more advanced FIGO stage and myometrial invasion. A negative correlation was observed between expression of ERRã mRNA and nodal metastasis (P=0.021).ERRá and ERRã are promising to be new prognostic factors in endometrial carcinoma.
See more of Cancer Research, Detection and Treatment
See more of Cancer Research, Detection and Treatment
See more of The UICC World Cancer Congress 2006
